GAO Memory Supplement Review Recalls FDA's Regulatory Challenges
This article was originally published in The Rose Sheet
Executive Summary
GAO recommends better cooperation between FDA and FTC and more public outreach are key to preventing consumers from believing noncompliant cognitive benefit claims for supplements.